Navigation Links
PeerJ PrePrints now free for all authors
Date:11/12/2013

PeerJ (an open access publisher of articles in the biological, life & medical sciences) today announced that all authors can now make unlimited submissions to PeerJ PrePrints entirely for free. Previously authors without a PeerJ publication plan could only publish one free preprint per year and so this represents a significant new benefit for authors.

PeerJ has been publishing 'PeerJ PrePrints' (an innovative pre-print server for un-peer reviewed articles in the biological, health and medical sciences) since April 2013. Since that time, almost 100 preprints have been published, some of which have received more than 5,000 views. Reflective of the diverse ways in which preprints are being used by authors, many have been revised multiple times; several have gone on to be published as formal peer-reviewed articles in PeerJ (and other journals); several have received multiple instances of 'review level' feedback from readers; several have been submitted by 'citizen scientists'; and one preprint was even used as a way to get work into the world despite the US Government shutdown. Preprints have also been used as a way for conferences to build up a complete record of their conference output.

Thus, PeerJ has demonstrated that there is a strong desire from the community to publish preprints. It is a core belief of PeerJ to maximize the ability of all authors to publish their work as freely as possible, and as a result this new policy ensures that as many people as possible are able to do so. Henceforth any author will be allowed to publish as many PeerJ PrePrints as they wish, without needing to take out a paid PeerJ publication plan.


'/>"/>

Contact: Peter Binfield
press@peerj.com
PeerJ
Source:Eurekalert

Page: 1

Related biology news :

1. PeerJ launches PeerJ PrePrints -- a preprint server for the biological and medical sciences
2. PeerJ publishes its first articles
3. NRC authors brief federal agencies on the state of polar regions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2016)... Global Market Watch: Primarily supported by ... Banks and Academics) market is to witness a value of ... the highest Compounded Annual Growth Rate (CAGR) of 10.75% is ... analysis period 2014-2020. North America is ... Europe at 9.56% respectively. Report ...
(Date:11/14/2016)... Technology, Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), ... in challenging operating environments, announced its results for the ... a conference call to discuss these results on November ... Key Recent Accomplishments ... acquire Vislink Communication Systems. The purchase is expected to ...
(Date:6/22/2016)... -- On Monday, the Department of Homeland Security (DHS) ... for the Biometric Exit Program. The Request for Information ... explains that CBP intends to add biometrics to confirm ... States , in order to deter visa overstays, ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... DIEGO, Dec. 8, 2016  OncoSec Medical Incorporated ... developing DNA-based intratumoral cancer immunotherapies, today announced financial ... "We are delivering on our commitment ... with ImmunoPulse┬« IL-12. We are pleased with the ... combination trial, and we are focused on advancing ...
(Date:12/8/2016)... , Dec. 8, 2016 Eurofins announces the appointment of ... President of Eurofins Scientific Inc. (ESI). Mr. Murray ... proven professional and entrepreneurial experience in leading international business teams. As ... food testing market to uphold Eurofins, status as the global leader ... , ...
(Date:12/8/2016)... 8, 2016  Anaconda BioMed S.L., a pre-clinical stage ... next generation neuro-thrombectomy system for the treatment of Acute ... Jovin, MD to join its Scientific Advisory Board (SAB). ... network of scientific and clinical experts to Anaconda BioMed ... ANCD BRAIN ┬« to its clinical phase. The ...
(Date:12/8/2016)... N.J. , Dec. 8, 2016  Soligenix, ... late-stage biopharmaceutical company focused on developing and commercializing ... an unmet medical need, announced today the long-term ... with SGX942 (dusquetide), a first-in-class Innate Defense Regulator ... in head and neck cancer patients undergoing chemoradiation ...
Breaking Biology Technology: